Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and endothelin-1

rosiglitazone has been researched along with endothelin-1 in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (55.56)29.6817
2010's8 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E1
Amiri, F; Diep, QN; Iglarz, M; Lavoie, MF; Schiffrin, EL; Touyz, RM1
Amiri, F; Diep, QN; Iglarz, M; Paradis, P; Schiffrin, EL; Touyz, RM; Viel, EC1
Evans, M; Rees, A; Roberts, AW; Thomas, A1
Bell, D; McDermott, BJ1
Bakris, GL; Sarafidis, PA1
Chen, MF; Chen, WJ; Cheng, WC; Lee, YT; Lin, JW; Wang, TD1
Li, Y; Liu, MY; Wang, YG1
Chen, DZ; Guo, J; Niu, XL; Pei, JM; Wang, WQ; Zhou, XD; Zhu, MZ; Zhu, XL; Zhu, XX1
Bao, Y; Cai, B; Chen, S; Gao, J; Jiang, J; Le, K; Li, R; Liu, P; Zhang, F1
Glover, PH; Jones, AV; Maric, C; McLemore, GR; Racusen, LC; Reckelhoff, JF; Ryan, MJ; Sartori-Valinotti, JC; Venegas-Pont, M1
Bae, EH; Kim, IJ; Kim, SW; Ma, SK1
Huang, Y; Tian, J; Tian, XY; Wang, N; Wong, WT; Zhang, P1
Kim, EK; Lee, JH; Lee, SD; Lee, YS; Oh, YM1
Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC1
Bijli, KM; Carthan, KA; Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, KK; Searles, CD; Sutliff, RL; Yeligar, SM1
Archer, D; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Park, K; Sutliff, RL1

Reviews

2 review(s) available for rosiglitazone and endothelin-1

ArticleYear
Peroxisome proliferator-activated receptor-gamma agonists in atherosclerosis: current evidence and future directions.
    Current opinion in lipidology, 2003, Volume: 14, Issue:6

    Topics: Albuminuria; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Carotid Arteries; Coronary Restenosis; Diabetes Mellitus, Type 2; Endothelin-1; Endothelium, Vascular; Humans; Hyperglycemia; Insulin Resistance; Lipoproteins; Matrix Metalloproteinases; Metformin; Muscle, Smooth, Vascular; Pioglitazone; Plasminogen Activator Inhibitor 1; PPAR gamma; Rosiglitazone; Thiazolidinediones

2003
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
    Kidney international, 2006, Volume: 70, Issue:7

    Topics: Albuminuria; Animals; Blood Pressure; Chromans; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Humans; Hypoglycemic Agents; Kidney; Kidney Failure, Chronic; Pioglitazone; PPAR gamma; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Rosiglitazone; Thiazolidinediones; Time Factors; Troglitazone

2006

Trials

1 trial(s) available for rosiglitazone and endothelin-1

ArticleYear
Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
    The American journal of cardiology, 2006, Oct-15, Volume: 98, Issue:8

    Topics: Arginine; Blood Pressure; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cholesterol, HDL; Endothelin-1; Endothelium-Dependent Relaxing Factors; Female; Glucose; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Regression Analysis; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vasodilator Agents

2006

Other Studies

15 other study(ies) available for rosiglitazone and endothelin-1

ArticleYear
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine

2016
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

2017
Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Jan-01, Volume: 23, Issue:1

    Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Endothelins; Extracellular Matrix; Fenofibrate; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Oxygen; Protein Precursors; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tunica Media; Vascular Resistance; Vasodilator Agents

2003
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
    Hypertension (Dallas, Tex. : 1979), 2003, Volume: 42, Issue:4

    Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Desoxycorticosterone; Endothelin-1; Endothelins; Fenofibrate; Fibrosis; Heart; Heart Ventricles; Hypertension; Myocardium; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Ventricular Remodeling

2003
Effects of rosiglitazone and interactions with growth-regulating factors in ventricular cell hypertrophy.
    European journal of pharmacology, 2005, Jan-31, Volume: 508, Issue:1-3

    Topics: Animals; Cell Survival; Cells, Cultured; Culture Media; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Endothelin-1; Glucose; Heart Ventricles; Hypertrophy; Insulin; Insulin-Like Growth Factor I; Isoproterenol; Male; Myocytes, Cardiac; Norepinephrine; Phenylalanine; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tetradecanoylphorbol Acetate; Thiazolidinediones

2005
[Effects of Shengqi Jiangtang Granule on rat model of insulin resistance and its mechanism].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:5

    Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelin-1; Hypoglycemic Agents; Insulin Resistance; Male; Phytotherapy; Protein Kinase C; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Treatment Outcome

2007
[Inhibitory effects of rosiglitazone against endothelin-1-induced proliferation of rat cardiac myocytes: the role of PKC-c-fos pathway].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:6

    Topics: Animals; Animals, Newborn; Blotting, Western; Cell Enlargement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Hypoglycemic Agents; Myocytes, Cardiac; Protein Kinase C; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Tetradecanoylphorbol Acetate; Thiazolidinediones

2008
Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
    Molecular and cellular biochemistry, 2008, Volume: 317, Issue:1-2

    Topics: Animals; Animals, Newborn; Calcineurin; Cardiomegaly; Cell Nucleus; Cell Size; Cyclosporine; Endothelin-1; Myocytes, Cardiac; NFATC Transcription Factors; PPAR gamma; Protein Biosynthesis; Protein Transport; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Surface Properties; Thiazolidinediones

2008
Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2009, Volume: 296, Issue:4

    Topics: Albuminuria; Animals; Antihypertensive Agents; Blood Pressure; Chemokine CCL2; Disease Models, Animal; Endothelin-1; Female; Hypertension; Kidney; Kidney Diseases; Lupus Erythematosus, Systemic; Macrophages; Mice; Monocytes; Osteopontin; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones

2009
Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:3

    Topics: Animals; Cyclooxygenase 2; Desoxycorticosterone; Disease Models, Animal; Endothelin-1; Glomerulonephritis; HSP27 Heat-Shock Proteins; Hypertension; Kidney; Male; Nephritis, Interstitial; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1

2010
Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor.
    Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:1

    Topics: Animals; Blotting, Northern; Blotting, Western; Cells, Cultured; Chromatin Immunoprecipitation; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Gene Expression Regulation; Humans; Hypoglycemic Agents; Immunohistochemistry; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rosiglitazone; Thiazolidinediones; Vasoconstriction; Vasodilator Agents

2010
Rosiglitazone attenuates hypoxia-induced pulmonary arterial hypertension in rats.
    Respirology (Carlton, Vic.), 2010, Volume: 15, Issue:4

    Topics: Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Hypoxia; Male; PPAR gamma; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factors

2010
The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo.
    American journal of physiology. Lung cellular and molecular physiology, 2011, Volume: 301, Issue:6

    Topics: Animals; Aspartic Acid Endopeptidases; Cell Hypoxia; Cell Proliferation; Endothelial Cells; Endothelin-1; Endothelin-Converting Enzymes; Gene Expression; Gene Expression Regulation; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; NF-kappa B; PPAR gamma; Pulmonary Artery; Receptor, Endothelin A; Receptor, Endothelin B; Rosiglitazone; Signal Transduction; Thiazolidinediones

2011
Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
    American journal of respiratory cell and molecular biology, 2016, Volume: 54, Issue:1

    Topics: 3' Untranslated Regions; Animals; Binding Sites; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelin-1; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Hypoxia; Indoles; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; PPAR gamma; Pulmonary Artery; Pyrroles; RNA Interference; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transfection; Vascular Remodeling

2016
Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    American journal of respiratory cell and molecular biology, 2017, Volume: 56, Issue:1

    Topics: Anemia, Sickle Cell; Animals; Blood Pressure; Endothelial Cells; Endothelin-1; Gene Knockdown Techniques; Hemin; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ligands; Lung; Mice; MicroRNAs; Models, Biological; PPAR gamma; Proto-Oncogene Protein c-ets-1; Pulmonary Artery; Rosiglitazone; Systole; Thiazolidinediones; Up-Regulation

2017